REYKJAVIK, Iceland, March 27, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO, or the "Company”), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...
Verisure’s majority owner Hellman & Friedman has lined up more banks for a potential initial public offering of the security ...
Fourth quarter 2024 revenue totaled $3.04 million, an increase of 181%, as compared to $1.08 million for the same period the prior year Full year 2024 revenue totaled $8.69 million, an increase of 112 ...
Private equity funds that own German drugmaker Stada Arzneimittel AG have decided to postpone its planned initial public ...
A broad coalition of civil society is calling on governments around the world to take urgent action to protect forests as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback